4//SEC Filing
Zocca Mai-Britt 4
Accession 0001140361-23-038881
CIK 0001865494other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 8:43 PM ET
Size
7.7 KB
Accession
0001140361-23-038881
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Zocca Mai-Britt
DirectorChief Executive Officer
Transactions
- Award
Warrants (Right to Buy)
2023-08-09$0.13/sh+37,037$4,630→ 37,037 totalExercise: $2.47From: 2023-08-09→ Common Stock (37,037 underlying) - Award
Common Stock
2023-08-09$1.90/sh+37,037$70,370→ 37,391 total
Holdings
- 26,580(indirect: Zocca Consulting ApS)
Common Stock
Footnotes (2)
- [F1]The reporting person is the sole owner of Zocca Consulting ApS and, in such capacity, may be deemed to beneficially own the shares held directly by Zocca Consulting ApS. The reporting person disclaims beneficial ownership of the shares held directly by Zocca Consulting ApS except to the extent of her pecuniary interest therein.
- [F2]These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023.
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
Related Parties
1- filerCIK 0001890736
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 8:43 PM ET
- Size
- 7.7 KB